Home・Stock List・Actinium Pharmaceuticals Inc

Actinium Pharmaceuticals Inc

Closed

1.01 -2.88

Buy Sell

Overview

Share price change

24h

Current

Min

Max

1.03

Key metrics
By Trading Economics
Income	33M 28M
Sales	35M 35M
P/E Sector Avg	2.914 56.659
EPS	0.89
Profit margin	79.717
Employees	27
EBITDA	33M 28M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+233.33% upside

Dividends
By Acuity
Next Earnings	12 Nov 2026

Market Stats
By TradingEconomics
Market Cap	6.5M 32M
Previous open	3.89
Previous close	1.01

Actinium Pharmaceuticals Inc Chart

Past performance is not a reliable indicator of future results.

Related News

4 Sept 2026, 23:56 UTC

Correlated Moves

Macy's Inc shares are lower in after-market trading, influenced by a decline in Kohl's Corp and broader retail sector challenges.

4 Sept 2026, 23:56 UTC

Southern Co. shares traded roughly flat in after-market hours, remaining below their 20-day moving average and near the lower end of their one-month range.

4 Sept 2026, 23:56 UTC

Redwood Trust shares rose in after-market trading, amid rising Treasury yields and stable unemployment. The stock remains below its 20-day moving average.

4 Sept 2026, 23:55 UTC

Mastercraft Boat Holdings Inc shares are higher in after-market hours. No specific news was identified to explain the movement.

4 Sept 2026, 23:55 UTC

TE Connectivity PLC shares are higher in after-market trading. No specific company news was identified to explain this movement.

4 Sept 2026, 23:55 UTC

Ameriprise Financial Inc shares are higher in after-market trading, influenced by stable labor market data and expectations for an interest rate hike.

4 Sept 2026, 23:55 UTC

Incyte Corp shares are higher in after-market hours, reaching an early peak before settling back. No specific news was identified to explain the movement.

4 Sept 2026, 23:55 UTC

Fastenal Co. shares moved higher in after-market trading, recovering from earlier losses amid rising Treasury yields and steady unemployment data.

4 Sept 2026, 23:51 UTC

International Bancshares Corp. shares remained roughly flat during after-market hours, following four consecutive sessions of higher performance. No specific news was identified.

4 Sept 2026, 23:51 UTC

Cytokinetics Inc shares are higher in after-market trading, reaching their highest cumulative return of the day, despite no specific news driving the move.

4 Sept 2026, 23:51 UTC

Tecnoglass Inc shares are trading higher in after-market hours, marking five consecutive sessions of gains. No specific news was identified to explain the movement.

4 Sept 2026, 23:51 UTC

CGI Inc shares are lower in after-market hours, continuing a decline since Friday's close. The stock remains significantly below its 20-day moving average.

4 Sept 2026, 23:51 UTC

CME Group Inc shares are higher in after-market hours, reflecting strong performance as they approach the upper end of their one-month trading range.

4 Sept 2026, 23:51 UTC

Axon Enterprise Inc shares are trading higher in after-market hours. No specific news was identified to explain this movement.

4 Sept 2026, 23:51 UTC

Kohls Corp shares are lower in after-market hours amid weak trading and mixed economic signals, including rising unemployment and slowing wage growth.

4 Sept 2026, 23:51 UTC

Nextera Energy Inc shares are lower in after-market hours, breaking a recent trend of higher daily closes amid a slight uptick in unemployment rates.

4 Sept 2026, 23:51 UTC

EPR Properties shares are higher in after-market hours, reflecting unusual strength despite no specific company news amid mixed economic signals and interest rate expectations.

4 Sept 2026, 23:51 UTC

Tapestry Inc shares are higher in after-market hours, recovering from an early dip. The stock remains below its 20-day moving average.

4 Sept 2026, 23:51 UTC

ECB Set to Announce Deposit Facility Rate Hike Amid Inflation Concerns and Geopolitical Tensions on September 10, 2026.

4 Sept 2026, 23:50 UTC

Wesco International Inc shares are higher in after-market hours, continuing a trend of recent gains and unusual trading activity noted earlier in the session.

4 Sept 2026, 23:50 UTC

Weyerhaeuser Co shares are higher in after-market trading, reflecting an increase since Friday's close, despite remaining below the 20-day moving average.

4 Sept 2026, 23:46 UTC

Antero Midstream Corp. shares showed little change during after-market hours, fluctuating within a narrow range and remaining above the 20-day moving average.

4 Sept 2026, 23:46 UTC

Correlated Moves

US Bancorp shares are lower in after-market trading amid mixed macroeconomic signals and a decline in Live Oak Bancshares, reflecting broader market sentiments.

4 Sept 2026, 23:46 UTC

Biogen Inc shares are lower in after-market hours, with no specific news driving the decline. Broader economic signals are contributing to market uncertainty.

4 Sept 2026, 23:46 UTC

Enovix Corp shares are higher in after-market trading, though no specific news was identified to explain the movement. Broader market dynamics influenced investor sentiment.

4 Sept 2026, 23:45 UTC

Hershey Co. shares gained in after-market trading, reflecting routine performance amid broader market dynamics, despite earlier fluctuations after Friday's close.

4 Sept 2026, 23:45 UTC

First American Financial shares higher in after-market trading, reflecting broader market movements amid shifting expectations for interest rates and recent economic data.

4 Sept 2026, 23:45 UTC

Iron Mountain Inc is trading lower in after-market hours, with no specific news identified. The stock remains near its one-month low and below its 20-day moving average.

4 Sept 2026, 23:45 UTC

Social Media

NIO Inc. CEO William Li discussed "operational quality" in a closed-door meeting. Shares traded roughly flat during after-market hours following the discussion.

4 Sept 2026, 23:45 UTC

Lucid Group Inc. shares are trading lower in after-market hours, continuing a trend of weakness amid broader market declines and remaining below the 20-day moving average.

Peer Comparison

Price change

Actinium Pharmaceuticals Inc Forecast

Price Target

By TipRanks

233.33% upside

12 Months Forecast

Average 3.5 USD 233.33%

High 4 USD

Low 3 USD

Based on 2 Wall Street analysts offering 12 month price targets forActinium Pharmaceuticals Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

Buy

Hold

Sell

Based on 2 analysts giving stock ratings to Actinium Pharmaceuticals Inc - Dist in the past 3 months.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Actinium Pharmaceuticals Inc

Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies. Its Iomab-B is an induction and conditioning agent prior to bone marrow transplant in patients with relapsed and refractory acute myeloid leukemia (r/r AML). The company focuses on advancing its development for product candidate Actimab-A, a therapeutic agent that has demonstrated potential activity in r/r AML patients. In addition, it engages with the National Cancer Institute under the cooperative research and development agreement for the development of Actimab-A in AML and other myeloid malignancies. Its Iomab-ACT, a next generation conditioning candidate, is being developed for improving patient access and outcomes for curative cell and gene therapies. Further, the company's research and development activities primarily focus on advancing various preclinical programs for solid tumor indications. The company holds approximately 235 patents and patent applications, including various patents related to the manufacture of the isotope Ac-225 in a cyclotron. The company is based in New York, New York.